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journal homepage: www.t jog-onl ine.comEditorialNeoplasms in the trocar site and peritoneal papillary serous
cystadenocarcinomaIn the previous issue of this journal (Volume 51, Number 3, pp.
463e464), Wang and colleagues [1] published a very interesting
research letter entitled “Peritoneal papillary serous cystadenocarci-
noma at a previous laparoscopic trocar site”. They concluded that
the patient in their study had a grade III, stage IV peritoneal papil-
lary serous adenocarcinoma, and that this may be correlated with
the fact that she had previously undergone a laparoscopic surgery
for ovarian endometriosis. In brief, this isolated serous carcinoma
was found in the left lower abdominal quadrant area of this 38-
year-old woman (G0P0), who had a history of laparoscopic cystec-
tomy 3 years previously for a left ovarian chocolate cyst. At that
time, the patient was treated with complete excision of the tumor,
which was located on the abdominal muscular layer. This patient
also underwent a relatively staging surgery, including pelvic and
para-aortic lymph node dissection, infracolic omentectomy, exci-
sion of the endometriotic foci, right and left ovarian biopsies, and
peritoneal washing [1]. Although the description of the ﬁnal pa-
thology was not clear, it appeared to be an isolated lesion within
the abdominal wall. Subsequently, the patient received six cycles
of carboplatin and paclitaxel with more than 2 years disease-free
survival.
This research letter provided at least three important issues: (1)
safety and feasibility of laparoscopic surgery in the management of
ovarian tumors; (2) the correlation between endometriosis and
ovarian cancer; and (3) the diagnosis of primary peritoneal serous
carcinoma.
First, the authors highlighted the fact that the surgical technique
used during a laparoscopic surgery may cause wound implantation
[1]. In fact, laparoscopic surgery has grown in popularity and might
be considered one of the standards or options in the management
of many kinds of diseases, including ectopic pregnancy [2], endo-
metriosis [3], and other gynecological diseases [4]. Many proce-
dures should be used for laparoscopic surgeries or other
surgeries, including a delicate surgical technique [5], complete exci-
sion together with removal of the intact tumor avoiding spillage [6],
and a protective procedure to prevent wound contamination from
resected tumor-laden specimens that involves the use of a cello-
phane bag, which was initially designed to prevent the leakage of
bile or gallstones into the peritoneal cavity [7]. All are not only
applicable for malignant or complex tumors [8,9] but may also be
used for benign tumors, such as mature teratoma [10], because
some of them caused a catastrophic situation [11]. In this research
letter, it is not clear whether the patient received laparoscopic cys-
tectomy for her chocolate cyst using an endobag to remove the
excised specimen [1].
Second, it is clear that endometriosis is a risk factor for epithe-
lial ovarian cancers, especially contributing to the clear-cell andhttp://dx.doi.org/10.1016/j.tjog.2014.04.002
1028-4559/Copyright  2014, Taiwan Association of Obstetrics & Gynecology. Publishedendometrioid histotypes [9]. However, the relation between
other histotypes, for example, high- or low-grade serous types,
and endometriosis is still uncertain. A recent paper by Pearce
and colleagues [12] reported a relation between endometriosis
and low-grade serous invasive ovarian cancer. Their ﬁndings sug-
gest a relation between endometriosis and the entire type I
ovarian cancer group, based on the following ﬁndings: (1) most
endometrioid and clear-cell ovarian cancers are derived from
endometriosis; and (2) low-grade serous ovarian cancers may
develop through papillary tubal hyperplasia, sloughing and im-
plantation of tubal epithelium on the ovarian surface or perito-
neum, and progression to atypical endosalpingiosis and
eventually low-grade serous adenocarcinoma [10]. Taken
together, type I invasive ovarian cancers can be classiﬁed as a
type of pelvic contamination disorder secondary to sloughing of
müllerian cells from the fallopian tubes [10]. The authors re-
ported that in their case, a laparoscopic operation was performed
to remove a benign ovarian endometrioma [1], which indirectly
hints that this isolated serious carcinoma might be correlated
with the previous endometrioma. By deﬁnition, only the pres-
ence of atypical endometriosis can be regarded as a precursor
lesion of clear- or endometrioid-cell ovarian cancers [13]; there-
fore, more detailed information, such as any endometriosis or ev-
idence of malignant transformation found in the excised tumor or
its surrounding tissue in this high-grade serous carcinoma, would
have been particularly helpful [1].
Third, the diagnosis of primary peritoneal serous carcinoma can
be discussed. In our previous experience [14], we also reported a
very similar case of a solitary peritoneal metastasis from a poorly
differentiated adenocarcinoma of unknown origin in a 38-year-
old female, who underwent complete excision of the tumor and
received six courses of postoperative adjuvant cisplatin-based com-
bination plus radiation therapy simultaneously and is still alive and
well after more than 10 years. In addition, according to the diag-
nostic criteria of primary peritoneal serous carcinoma from the Gy-
necologic Oncology Group, (1) both ovaries must be normal in size
(<4 cm in largest diameter) or enlarged by a benign process; (2) tu-
mor involvement at the extraovarian sitesmust be greater than that
on the surface of either ovary; (3) microscopically, the ovarian
component must be nonexistent, conﬁned to ovarian surface
epithelium with no evidence of cortical invasion, involving surface
epitheliumwith less than 5mm 5mmwithin the stroma; and (4)
histologic and cytologic characteristics of the tumor must be pre-
dominantly of the serous type or identical to any grade of ovarian
papillary tumor [15]. Taken together, we suggest that this could
be a case a poorly differentiated adenocarcinoma of unknown
origin in place of a primary peritoneal serous cystadenocarcinomaby Elsevier Taiwan LLC. All rights reserved.
Editorial / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 139e140140as the authors had concluded [1], because we are not entirely
convinced that an assumption of peritoneal papillary serous cysta-
denocarcinoma could be made based only on an isolated malig-
nancy within the abdominal wall.
Nevertheless, we congratulate Dr Wang and his colleagues [1]
for their successful efforts, as their excellent work in the manage-
ment of this patient is worthy of being applauded.
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